SANTO Company is a member of Polpharma international pharmaceutical group that is operating in the markets of Central and Eastern Europe, Caucasus and Central Asia. The Сompany develops, produces and supplies high-quality and affordable medical products to the markets of Kazakhstan and Central Asia. The Company’s production capacities enable it to produce annually 806 million tablets, capsules and granules; 131 million ampoules with injection solutions; 1.8 million bags and bottles with infusion solutions; 23 million vials of antibiotic powders (cephalosporins); 10 million vials of antibiotic powders (penemes / mycins); 4.2 million vials of liquid oral medicine products.
With its portfolio that includes over 240 generic drugs which are used in 12 different therapeutic categories for treatment of diseases in various therapeutic fields SANTO Company is the leader of the pharmaceutical market of Kazakhstan.
The Company currently implements the largest investment project on the modernization of existing pharmaceutical industries in accordance with GMP international standards, the investment volume of which is about 108 million US dollars.
The company possesses certifications of compliance with the international standard of Good Manufacturing Practice (GMP) for its: manufacturing site for the production of injectable solutions and infusions, manufacturing site for the production of solid oral medicines, production line of infusion solutions, and production site for aseptic filling of antibiotic powders. The company’s pharmaceutical warehouse posses a certificate for the compliance of the standard for good distribution practice (GDP).
The company exports its products into the markets of 8 countries: Russia, Ukraine, Kyrgyzstan, Mongolia, Uzbekistan, Turkmenistan, Tajikistan, and fulfills requirements for the domestic market.